AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?

Show other versions (1)

<p>Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab (FCR) has been established as the current standard of care for young and fit patients with chronic lymphocytic leukemia (CLL). In the early nineties of the last century, long before the advent of fludarabine or ant...

Full description

Bibliographic Details
Published in:Mediterranean Journal of Hematology and Infectious Diseases
Main Authors: Fabienne McClanahan, Peter Dreger
Format: Article
Language:English
Published: PAGEPress Publications 2012-01-01
Subjects:
CLL
autologous transplantation
survival
high-risk patients
secondary malignancies
Online Access:http://www.mjhid.org/article/view/11074

Internet

http://www.mjhid.org/article/view/11074

Similar Items